After 15 years of running the Higher Training Scheme (HTS), the British Academy of Audiology (BAA) relaunched its postgraduate training scheme this year. We hear about the updated scheme and how it combines theoretical study and clinical training to provide...
An innovative and inclusive approach to the identification and prioritisation of research questions is to place the views of patients at the heart of the process, and in partnership with clinicians. The application of this to hyperacusis is described by...
The COVID-19 pandemic has changed all aspects of our lives – not least medical education. With isolation being the buzzword at the moment, the internet and social media are popular sources for official and crowd-sourced content. In this article, Samantha...
Recent events, including the COVID-19 pandemic, have once again highlighted health inequalities experienced by people from ethnic minority backgrounds. Our Editors’ Choice paper shows that there are inequalities in hearing aid use and includes the stark finding that ethnicity is...
BIOHIT HealthCare is pleased to extend its corporate partnership with the British Laryngological Association (BLA) for a second year running, supporting its pursuit of improved diagnosis for laryngopharyngeal reflux (LPR).
Widex UK & Ireland and Anglia Ruskin University (ARU) announced in July, an exciting project designed to create added value for independent hearing care professionals and future audiology graduates within the UK & Ireland.
Intraoperative neuromonitoring has become a standard practice in all thyroid surgery, allowing for the precise localisation and reliable monitoring of neurophysiological structures at-risk.
BIOHIT HealthCare is pleased to announce that a clinical study conducted by Homerton University Hospital NHS Foundation Trust, London, has confirmed the diagnostic accuracy of GastroPanel in identifying gastric cancer risk in patients with upper abdominal complaints. This study demonstrated...
BIOHIT HealthCare Ltd will be attending the upcoming BSG Live 2023 conference in Liverpool, where it will unveil a revolutionary new test to support decision making for gastroscopy referrals and improve the early detection of gastric cancer.
The family-owned MedTech company KARL STORZ announces the acquisition of the innovative software manufacturer Innersight Labs Ltd. (ISL) headquartered in London.
Although the vast majority of septoplasties in the UK are performed as day surgery procedures, the authors of this article highlight the differences in healthcare in Germany. The authors calculated a yearly cost reduction of 180 million euros if the...
This is a Canadian retrospective paper covering the period of March 2018 to March 2022. It identified 190 patients; 91 pre-pandemic and 99 from the pandemic. From this, they found there was no increase in patient delay, professional delay or...